Wits RHI
Clinical Research
Wits RHI is contributing to the landmark Phase 3 M72/AS01E TB vaccine trial, advancing research towards a new generation of TB prevention. Tuberculosis remains one of the world’s biggest infectious disease challenges. Wits RHI, led by Professor Lee Fairlie, is contributing to the Phase 3 M72/AS01E vaccine trial, an important global effort to develop a...
Footer
Established in 1994, Wits RHI is part of the Faculty of Health Sciences and a leading research institute of the University of the Witwatersrand.